Aim: This study determined the prevalence and risk factors associated with hepatitis B and C among the low-socioeconomic population. Materials & methods: A total of 1004 participants were screened for hepatitis B/C infection and risk factors from six different localities of Islamabad, Pakistan Results: The prevalence rate of hepatitis B and C was 1 and 4%, respectively. Chi-square test showed hepatitis B/C infection was related with marital status, hepatitis B vaccination, blood recipients and family income. Multivariable analysis showed hepatitis B vaccination, exposure to therapeutic injections, dental visits, exposure to HCV patients and age of participants were independently associated with hepatitis C infection. Conclusion: The risk of hepatitis B/C infection is multifactorial and the population needs to be vaccinated at a larger scale to avoid outbreaks.

Keywords:

References

1. Prevention and control of viral hepatitis infection: frame work for global action. 2012 (2020). www.who.int/hepatitis/publications/Framework/en/
Google Scholar
2. Lim JK, Nguyen MH, Kim WR, Gish R, Perumalswami P, Jacobson IM. Prevalence of chronic hepatitis B virus infection in the United States. Am. J. Gastroenterol. 115(9), 1429–1438 (2020).
MedlineGoogle Scholar
3. Petruzziello A, Marigliano S, Loquercio G, Cozzolino A, Cacciapuoti C. Global epidemiology of hepatitis C virus infection: an up-date of the distribution and circulation of hepatitis C virus genotypes. World J. Gastroenterol. 22(34), 7824 (2016).
MedlineGoogle Scholar
4. Wiktor SZ, Hutin YJ. The global burden of viral hepatitis: better estimates to guide hepatitis elimination efforts. Lancet 388(10049), 1030 (2016).
MedlineGoogle Scholar
5. World Health Organization. Combating hepatitis B and C to reach elimination by 2030: advocacy brief (2016). https://apps.who.int/iris/handle/10665/206453
Google Scholar
6. Attaullah S, Khan S, Ali I. Hepatitis C virus genotypes in Pakistan: a systemic review. Virol. J. 8(1), 1–6 (2011).
MedlineGoogle Scholar
7. Chen CL, Huang JY, Wang CH et al. Hepatitis C virus has a genetically determined lymphotropism through co-receptor B7. 2. Nat. Commun. 8(1), 1–17 (2017).
MedlineGoogle Scholar
8. Geller R, Estada Ú, Peris JB et al. Highly heterogeneous mutation rates in the hepatitis C virus genome. Nat. Microbiol. 1(7), 1–7 (2016).
Google Scholar
9. Yokokawa H, Higashino A, Suzuki S et al. Induction of humoural and cellular immunity by immunisation with HCV particle vaccine in a non-human primate model. Gut 67(2), 372–379 (2018).
Medline CASGoogle Scholar
10. Selzer L, Zlotnick A. Assembly and release of hepatitis B virus. Cold Spring Harb. Perspect. Med. 5(12), a021394 (2015).
MedlineGoogle Scholar
11. World Health Organization. Hepatitis B (2020). www.who.int/news-room/fact-sheets/detail/hepatitis-b
Google Scholar
12. Haqqi A, Munir R, Khalid M et al. Prevalence of hepatitis C virus genotypes in Pakistan: current scenario and review of literature. Viral Immunol. 32(9), 402–413 (2019).
Medline CASGoogle Scholar
13. Mehmood S, Raza H, Abid F et al. National prevalence rate of hepatitis B and C in Pakistan and its risk factors. J. Public Health 28(6), 751–764 (2020).
Google Scholar
14. Ringehan M, Mckeating JA, Protzer U. Viral hepatitis and liver cancer. Philos. Trans. R. Soc. Lond., B, Biol. Sci. 372(1732), 20160274 (2017).
MedlineGoogle Scholar
15. Kvitko DT, Bastos GaN, Pinto MEB. Prevalence of risk factors for hepatitis C and associated factors: a population-based study in southern Brazil. Arq. Gastroenterol. 50, 117–122 (2013).
MedlineGoogle Scholar
16. Omland LH, Osler M, Jepsen P et al. Socioeconomic status in HCV infected patients–risk and prognosis. Clin. Epidemiol. 5, 163 (2013).
MedlineGoogle Scholar
17. Lim AG, Walker JG, Mafirakureva N et al. Effects and cost of different strategies to eliminate hepatitis C virus transmission in Pakistan: a modelling analysis. Lancet Glob. Health 8(3), e440–e450 (2020).
MedlineGoogle Scholar
18. Mahmud S, Al Kanaani Z, Abu-Raddad LJ. Characterization of the hepatitis C virus epidemic in Pakistan. BMC Infect. Dis. 19(1), 1–11 (2019).
Medline CASGoogle Scholar
19. Sample size calculator – confidence level, confidence interval, sample size, population size, relevant population – creative research systems (2018). www.surveysystem.com/sscalc.htm
Google Scholar
20. Islamabad population 2020 (demographics, maps, graphs) (2020). https://worldpopulationreview.com/world-cities/islamabad-population
Google Scholar
21. Gétaz L, Casillas A, Siegrist CA et al. Hepatitis B prevalence, risk factors, infection awareness and disease knowledge among inmates: a cross-sectional study in Switzerland's largest pre-trial prison. J. Glob. Health 8(2), 020407 (2018).
MedlineGoogle Scholar
22. Martini S. Hepatitis C and liver transplantation. Minerva Gastroenterol. Dietol. 64(2), 158–169 (2017).
MedlineGoogle Scholar
23. Ataei B, Alavian SM, Shahriari-Fard F et al. A case-control study of risk factors for hepatitis B infection: a regional report among Isfahanian adults. J. Res. Med. Sci. 24, 22 (2019).
MedlineGoogle Scholar
24. Keshavarz K, Kebriaeezadeh A, Alavian SM et al. Economic burden of hepatitis B virus-related diseases: evidence from Iran. Hepat. Mon. 15(4), e25854 (2015).
MedlineGoogle Scholar
25. Edmunds BL, Miller ER, Tsourtos G. The distribution and socioeconomic burden of hepatitis C virus in South Australia: a cross-sectional study 2010–2016. BMC Public Health 19(1), 1–16 (2019).
MedlineGoogle Scholar
26. Satti R, Farah M, Khan MI et al. Prevalence of hepatitis C virus in urban Ghettos of twin cities. Pak. J. Zool. 44(4), 937–943 (2012).
Google Scholar
27. Khokhar N, Gill ML, Malik GJ. General seroprevalence of hepatitis C and hepatitis B virus infections in population. J. Coll. Physicians Surg. Pak. 14(9), 534–536 (2004).
MedlineGoogle Scholar
28. Samo AA, Laghari ZA, Baig NM, Khoso GM. Prevalence and risk factors associated with hepatitis B and C in Nawabshah, Sindh, Pakistan. Am. J. Trop. Med. 104(3), tpmd201228 (2020).
MedlineGoogle Scholar
29. Arshad A, Arshad M, Pervaiz R, Farzana J, Ahmad N, Ali IS. Prevalence of active hepatitis-C infection in the general population of district Mardan, Khyber Pakhtunkhwa. Pakistan Public Health Biol. Sci. 1(1), 3–8 (2012).
Google Scholar
30. Ul Huda W, Jameel N, Fasih U, Rehman A, Shaikh A. Prevalence of hepatitis B and C in urban patients undergoing cataract surgery. Pak. J. Ophthal. 29(3), 147–150 (2013).
Google Scholar
31. Akhtar N, Ilyas M, Muhammad K, Shams S, Saeed K, Asadullah A. Prevalence of Hepatitis C virus infections among the general population of Buner, Khyber Pakhtunkhwa, Pakistan. Biomed. Res. Ther. 3(12), 1003–1017 (2016).
Google Scholar
32. Yee LJ, Weiss HL, Langner RG, Herrera J, Kaslow RA, Van Leeuwen DJ. Risk factors for acquisition of hepatitis C virus infection: a case series and potential implications for disease surveillance. BMC Infect Dis. 1(1), 1–5 (2001).
MedlineGoogle Scholar
33. Akhtar AM, Majeed S, Jamil M, Rehman A. Prevalence of hepatitis C infection. Professional Med. J. 22(11), 1390–1396 (2015).
Google Scholar
34. Qureshi H, Bile K, Jooma R, Alam S, Afrid H. Prevalence of hepatitis B and C viral infections in Pakistan: findings of a national survey appealing for effective prevention and control measures. East. Mediterr. Health J. 16, 15–23 (2010).
MedlineGoogle Scholar
35. Chakrabarty P, Rudra S, Hossain MA. Prevalence of HBV and HCV among the multi-transfused beta thalassemic major patients in a day care centre of blood transfusion department of Mymensingh Medical College Hospital. Mymensingh Med. J. 23(2), 235–241 (2014).
Medline CASGoogle Scholar
36. Ejiofor O, Ibe B, Emodi I et al. The role of blood transfusion on the prevalence of hepatitis C virus antibodies in children with sickle-cell anaemia in Enugu, South East Nigeria. Niger. J. Clin. Pract. 12(4), 235–241 (2009).
Google Scholar
37. Adeyemi A, Omolade O, Raheem-Ademola R. Immunochromatographic testing method for hepatitis B, C in blood donors. J. Antivir. Antiretrovir. S 3, (2013).
Google Scholar
38. Jafari S, Buxton JA, Afshar K, Copes R, Baharlou S. Tattooing and risk of hepatitis B: a systematic review and meta-analysis. Can. J. Public Health 103(3), 207–212 (2012).
MedlineGoogle Scholar
39. Tohme RA, Holmberg SD. Transmission of hepatitis C virus infection through tattooing and piercing: a critical review. Clin. Infect. Dis. 54(8), 1167–1178 (2012).
MedlineGoogle Scholar
40. Carney K, Dhalla S, Aytaman A, Tenner CT, Francois F. Association of tattooing and hepatitis C virus infection: A multicenter case-control study. Hepatology 57(6), 2117–2123 (2013).
MedlineGoogle Scholar
41. Ziaee M, Ebrahimzadeh A, Azarkar Z et al. Seroprevalence and risk factors for hepatitis B in an adult population: the first report from Birjand, South Khorasan, Iran. Hepat. Mon. 16(9), e36452 (2016).
MedlineGoogle Scholar
42. Gacche RN, Al-Mohani SK. Seroprevalence and risk factors for hepatitis C virus infection among general population in central region of Yemen. Hepat. Res. Treat. 2012, 689726 (2012).
MedlineGoogle Scholar
43. Al Humayed SM. The risk of acquiring hepatitis B and C viral infections following tooth extraction in Al Farsha area, south-western Saudi Arabia. Saudi J. Oral. Dent. Res. 7(2), 127–131 (2016).
Google Scholar
44. Schillie S, Vellozzi C, Reingold A et al. Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices. Morb. Mortal. Wkly. Rep. 67(1), 1 (2018).
MedlineGoogle Scholar
45. Pereira LM, Martelli CM, Moreira RC et al. Prevalence and risk factors of hepatitis C virus infection in Brazil, 2005 through 2009: a cross-sectional study. BMC Infect. Dis. 13(1), 1–12 (2013).
MedlineGoogle Scholar
46. Pracoyo NE, Suratri MaL, Roselinda R, Setiawaty V. The association of hepatitis C serological status with several risk factors in Indonesia. Int. Sch. Res. Notices 2016, 3018135 (2016).
MedlineGoogle Scholar
47. Omar MZ, Metwally MA, El-Feky HM, Ahmed IA, Ismail MA, Idris A. Role of intrafamilial transmission in high prevalence of hepatitis C virus in Egypt. Hepat. Med. 9, 27–33 (2017).
MedlineGoogle Scholar
48. Xu H, Yu G, Sun H et al. Use of parenteral caffeinum natrio-benzoicum: an underestimated risk factor for HCV transmission in China. BMC Public Health 15(1), 1–6 (2015).
MedlineGoogle Scholar
49. Ayoub H, Al Kanaani Z, Abu-Raddad L. Characterizing the temporal evolution of the hepatitis C virus epidemic in Pakistan. J. Viral Hepat. 25(6), 670–679 (2018).
Medline CASGoogle Scholar

Vol. 17, No. 5

Metrics

Downloaded 26 times

History

Received 23 January 2021

Accepted 1 March 2022

Published online 11 April 2022

Published in print May 2022

Information

Keywords

Author contributions

This work was designed, conducted and written by A Noreen and F Adnan. N Alam, Z Syed, A Aftab and F Shamim helped in virus sequence analysis via various web tools and evaluated the manuscript. S Najeebullah, SJ Kakar and T Ahmed helped in statistical analysis and final editing of the manuscript.

Acknowledgments

The authors are very thankful to the Islamabad lab and research center for helping us in testing the samples.

Financial & competing interests disclosure

This project was funded by the student research fund of the National University of Sciences and Technology (NUST), Islamabad. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Ethical conduct of research

The proforma used was approved by the IRB committee at ASAB, NUST. Participants were well informed about the research work and the information to be published later.

PDF download